CA1075702A - Process for the preparation of substituted guanidine compounds - Google Patents

Process for the preparation of substituted guanidine compounds

Info

Publication number
CA1075702A
CA1075702A CA257,589A CA257589A CA1075702A CA 1075702 A CA1075702 A CA 1075702A CA 257589 A CA257589 A CA 257589A CA 1075702 A CA1075702 A CA 1075702A
Authority
CA
Canada
Prior art keywords
formula
hydroxymethyl
methyl
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA257,589A
Other languages
English (en)
French (fr)
Inventor
George R. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of CA1075702A publication Critical patent/CA1075702A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA257,589A 1975-07-31 1976-07-22 Process for the preparation of substituted guanidine compounds Expired CA1075702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31968/75A GB1565647A (en) 1975-07-31 1975-07-31 Pharmacologically active compounds 4-substituted-imidazole-5-methanols

Publications (1)

Publication Number Publication Date
CA1075702A true CA1075702A (en) 1980-04-15

Family

ID=10331071

Family Applications (1)

Application Number Title Priority Date Filing Date
CA257,589A Expired CA1075702A (en) 1975-07-31 1976-07-22 Process for the preparation of substituted guanidine compounds

Country Status (28)

Country Link
JP (1) JPS5219663A (ro)
AR (1) AR213100A1 (ro)
AT (1) AT356668B (ro)
AU (1) AU508262B2 (ro)
BE (1) BE843840A (ro)
CA (1) CA1075702A (ro)
CS (1) CS203054B2 (ro)
DD (1) DD125205A5 (ro)
DE (1) DE2634430A1 (ro)
DK (1) DK316376A (ro)
ES (1) ES450309A1 (ro)
FI (1) FI762191A (ro)
FR (1) FR2319341A1 (ro)
GB (1) GB1565647A (ro)
GR (1) GR61114B (ro)
HU (1) HU174068B (ro)
IL (1) IL50006A0 (ro)
LU (1) LU75495A1 (ro)
NL (1) NL7608505A (ro)
NO (1) NO762659L (ro)
OA (1) OA05405A (ro)
PH (1) PH13417A (ro)
PT (1) PT65377B (ro)
RO (1) RO72312B (ro)
SE (1) SE7608478L (ro)
SU (1) SU655310A3 (ro)
ZA (1) ZA763686B (ro)
ZM (1) ZM9676A1 (ro)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4112234A (en) 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0008596A1 (fr) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Procédé de préparation de dérivés du type 4-hydroxyméthyl imidazole à partir d'esters d'acides 4-imidazole carboxyliques correspondants
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
JPS5914460B2 (ja) * 1978-12-27 1984-04-04 相互薬工株式会社 Ｈ↓２受容体「きつ」抗剤シメチジンの製造法
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives

Also Published As

Publication number Publication date
GR61114B (en) 1978-09-13
ATA552376A (de) 1979-10-15
AU1644776A (en) 1978-02-02
RO72312A (ro) 1984-03-15
FR2319341B1 (ro) 1979-01-12
FR2319341A1 (fr) 1977-02-25
SU655310A3 (ru) 1979-03-30
PT65377A (en) 1976-08-01
JPS5219663A (en) 1977-02-15
PH13417A (en) 1980-03-30
AT356668B (de) 1980-05-12
ZA763686B (en) 1977-05-25
BE843840A (fr) 1977-01-06
NO762659L (ro) 1977-02-01
SE7608478L (sv) 1977-02-01
AR213100A1 (es) 1978-12-15
IL50006A0 (en) 1976-09-30
NL7608505A (nl) 1977-02-02
DK316376A (da) 1977-02-01
GB1565647A (en) 1980-04-23
LU75495A1 (ro) 1977-03-03
FI762191A (ro) 1977-02-01
CS203054B2 (en) 1981-02-27
OA05405A (fr) 1981-02-28
HU174068B (hu) 1979-10-28
DD125205A5 (ro) 1977-04-06
AU508262B2 (en) 1980-03-13
ES450309A1 (es) 1977-12-01
RO72312B (ro) 1984-03-31
PT65377B (en) 1978-01-19
DE2634430A1 (de) 1977-02-10
ZM9676A1 (en) 1977-07-21

Similar Documents

Publication Publication Date Title
US4098898A (en) Imidazolyl alkylguanidine compounds
US4255440A (en) Furan derivatives having selective action on histamine receptors
CA1076579A (en) Pharmacologically active guanidine derivatives
CA1075702A (en) Process for the preparation of substituted guanidine compounds
US3905984A (en) Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
CA1053242A (en) Heterocyclic guanidine derivatives
US4301165A (en) Pharmacologically active compounds
CA1067501A (en) Process for preparing substituted guanidines
CA1111040A (en) Process for preparing sulphonylamidine compounds
US4036971A (en) Amidino compounds
US4308275A (en) Thiazole and isothiazole compounds, pharmaceutical compositions and their method of use
US4000296A (en) Imidazole alkylguanidine compounds
US4285952A (en) Pyridyl, thiazolyl and isothiazolyl alkyl bisamidines
US4060621A (en) Pyridyl alkylguanidine compounds
CA1069904A (en) Pharmacologically active sulfoxide derivatives
US4166856A (en) Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
US4072748A (en) Certain guanidine compounds, and their use as inhibitors of histamine activity
US4120972A (en) Imidazolylmethylthio-ethyl isothiourea compounds
US4173644A (en) Thiourea compounds, compositions and methods and use
US4133886A (en) Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
US4192879A (en) Imidazolyl alkylamino nitroethylene compounds
US4129657A (en) Imidazole guanidines and use as inhibitors of histamine activity
US4093729A (en) N-Oxy and N-amino guanidines
CA1070316A (en) Pharmacologically active bis imidazolyl guanidines

Legal Events

Date Code Title Description
MKEX Expiry